BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Ming‐Lung Yu"”

8 results

APASL consensus statements and recommendation on treatment of hepatitis C

Verified

Masao Omata, Tatsuo Kanda, Lai Wei, Ming‐Lung Yu et al.

Journal: Hepatology InternationalYear: 2016Citations: 223

The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the "APASL consensus statements and recommendation on management of hepatitis C" in March, 2015, in order to revise "APASL consensus statements and management algorithms for hepatitis C virus ...

Health SciencesMedicineHepatologyOpen Access
Read Source

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Verified

Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, Vincent Wai‐Sun Wong et al.

Journal: Hepatology InternationalYear: 2025Citations: 123

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused ...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation

Verified

Tatsuo Kanda, George Lau, Lai Wei, Mitsuhiko Moriyama et al.

Journal: Hepatology InternationalYear: 2019Citations: 112

In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained virological response (SVR) is very high, but close attention must be paid to the possible occurrence of hepatocellular carcinoma (HCC) and reactivation of hepatitis B virus (HBV) in patients with co-infection w...

Health SciencesMedicineHepatologyOpen Access
Read Source

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

Verified

Xufen Zeng, Krista A Varady, Xiangdong Wang, Giovanni Targher et al.

Journal: MetabolismYear: 2024Citations: 107

Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention strategies for MAFLD are not standardized. This study aimed to achieve conse...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

Verified

Masao Omata, Tatsuo Kanda, Lai Wei, Ming‐Lung Yu et al.

Journal: Hepatology InternationalYear: 2016Citations: 95

The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on "APASL consensus statements and recommendations for management of hepatitis C" in March 2015 to revise the "APASL consensus statements and management algorithms for hepatitis C virus infection...

Health SciencesMedicineHepatologyOpen Access
Read Source

Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

Verified

Virendra Singh, Arka De, Rohit Mehtani, Paolo Angeli et al.

Journal: Hepatology InternationalYear: 2023Citations: 46
Health SciencesMedicineHepatologyOpen Access
Read Source

Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation

Verified

Dong‐Sik Kim, Young‐In Yoon, Beom Kyung Kim, Ashok Choudhury et al.

Journal: Hepatology InternationalYear: 2024Citations: 44

Liver transplantation is a highly complex and challenging field of clinical practice. Although it was originally developed in western countries, it has been further advanced in Asian countries through the use of living donor liver transplantation. This method of transplantation is the only available...

Health SciencesMedicineSurgeryOpen Access
Read Source

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Verified

Tatsuo Kanda, George Lau, Lai Wei, Mitsuhiko Moriyama et al.

Journal: Hepatology InternationalYear: 2018Citations: 32

Chronic hepatitis C virus (HCV) infection is common among patients with chronic kidney disease (CKD) and those on hemodialysis due to nosocomial infections and past blood transfusions. While a majority of HCV-infected patients with end-stage renal disease are asymptomatic, some may ultimately experi...

Health SciencesMedicineHepatologyOpen Access
Read Source
PreviousPage 1 of 1Next